Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Heart Failure Treatment and Management, Cardiac Structural Anomalies and Repair, Cardiac Fibrosis and Remodeling, and Cardiovascular Function and Risk Factors.
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF
Anti-senescence therapies: a new concept to address cardiovascular disease
Pregnancies in women after peri-partum cardiomyopathy: the global European Society of Cardiology EuroObservational Research Programme Peri-Partum Cardiomyopathy Registry
Finerenone and Atrial Fibrillation in Heart Failure
Sudden cardiac death in newly diagnosed non-ischaemic or ischaemic cardiomyopathy assessed with a wearable cardioverter-defibrillator: the German nationwide SCD-PROTECT study
Heart failure with reduced ejection fraction and ventricular secondary mitral regurgitation: a holistic approach
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial
Efficacy and Safety of CDR132L in Patients with Reduced Left Ventricular Ejection Fraction After Myocardial Infarction: Rationale and Design of the HF-REVERT Trial
Baseline Characteristics of Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial
Therapy duration and improvement of ventricular function in <i>de novo</i> heart failure: the Heart Failure Optimization study
Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction
Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry
Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registry
Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and human
Mineralocorticoid receptor promotes cardiac macrophage inflammaging
Catheter-Based Ablation to Improve Outcomes in Patients with Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction: Rationale and Design of the CABA-HFPEF-DZHK27 Trial
Circulating soluble fibroblast activation protein (FAP) levels are independent of cardiac and extra-cardiac FAP expression determined by targeted molecular imaging in patients with myocardial FAP activation
Hypoxia Attenuates Pressure Overload‐Induced Heart Failure
Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions
Pre-Discharge and Early Post-Discharge Management of Patients Hospitalized for Acute Heart Failure: A Scientific Statement by the Heart Failure Association of the ESC
Palliativmedizinische Aspekte in der klinischen Akut- und Notfallmedizin sowie Intensivmedizin
Acute Heart Failure and Valvular Heart Disease: A Scientific Statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
Management of Worsening Heart Failure With Reduced Ejection Fraction
Incidence, Risk Assessment and Prevention of Sudden Cardiac Death in Cardiomyopathies
Outcomes at One Year in Women with Peripartum Cardiomyopathy: Findings from the ESC EORP PPCM Registry
Efficacy of pharmacological and interventional treatment for resistant hypertension: a network meta-analysis